[Health] 7.Jan.2022
Guest: Dr Vidur Mahajan, CEO, CARPL
Everyone talks about AI transforming healthcare. Far fewer talk about how difficult it is to actually deploy it inside a hospital.
Dr Vidur Mahajan, CEO of CARPL, breaks down why radiology AI adoption has been slower than expected, from fragmented tools and regulatory hurdles to the real challenges of validation and scale. He explains how CARPL’s FDA-cleared, vendor-neutral AI marketplace helps healthcare systems deploy and manage multiple AI solutions through a single platform, whether they’re global institutions or clinics operating with limited infrastructure.
The discussion goes beyond technology to explore the human side of AI in medicine, including how clinicians learn to trust automation, the risks of scaling high-implication AI, and why clinical, operational and financial ROI ultimately determine success.



